glycocyamine has been researched along with Anti-MuSK Myasthenia Gravis in 2 studies
glycocyamine: RN given refers to parent cpd; structure
guanidinoacetate : A monocarboxylic acid anion that is the conjugate base of guanidinoacetic acid, obtained by deprotonation of the carboxy group.
guanidinoacetic acid : The N-amidino derivative of glycine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| TORDA, C | 1 |
| WOLFF, HG | 1 |
| BILLIG, HE | 1 |
| MOREHOUSE, LE | 1 |
2 other studies available for glycocyamine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Glycocyamine elimination in patients with myasthenia gravis.
Topics: Glycine; Humans; Myasthenia Gravis | 1946 |
Performance and metabolic alterations during betaine glycocyamine feeding in myasthenia gravis.
Topics: Betaine; Glycine; Humans; Myasthenia Gravis | 1955 |